DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Dalziel K, Round A, Stein K. et al.
Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis.
Health Technol Assess 2004;
28: 1-120
We do not assume any responsibility for the contents of the web pages of other providers.